Clinical Executive Summary
In female endocrinology, an isolated elevation of Dehydroepiandrosterone Sulfate (DHEA-S > 350 to 430 ug/dL) alongside completely normal Total and Free Testosterone points directly to an adrenal source of androgen excess rather than ovarian pathology. Because more than 99% of circulating DHEA-S is synthesized exclusively by the zona reticularis of the adrenal cortex via the sulfotransferase enzyme (SULT2A1), this pattern excludes classic ovarian hyperthecosis. The primary clinical considerations are Adrenal Polycystic Ovary Syndrome (Adrenal PCOS), driven by hypothalamic-pituitary-adrenal (HPA) axis hypersensitivity to ACTH; Non-Classic Congenital Adrenal Hyperplasia (NCAH), a mild genetic 21-hydroxylase deficiency requiring morning 17-hydroxyprogesterone screening; chronic psychological or sympathetic stress; and exogenous DHEA supplementation. Extreme values above 700 to 800 ug/dL warrant cross-sectional adrenal imaging to rule out autonomous cortical neoplasms.
Receiving an androgen panel showing a red flag next to DHEA-Sulfate (DHEA-S) while Testosterone remains perfectly normal is one of the most frequent clinical puzzles encountered in female health.
Patients often research elevated androgens and immediately encounter Polycystic Ovary Syndrome (PCOS). Yet many of these women do not match the textbook metabolic profile of PCOS: they have lean body mass, normal insulin sensitivity, regular menstrual cycles, and completely clear ovaries on pelvic ultrasound.
Understanding the difference between adrenal androgen production and ovarian androgen production unlocks the true diagnosis, preventing misdirected treatments and identifying the real endocrine root cause.
1. Adrenal vs Ovarian Androgen Synthesis: Anatomy Matters#
To understand why DHEA-S and testosterone diverge, one must trace their anatomical origin in the female body:
[FEMALE ANDROGEN BIOSYNTHESIS COMPARTMENTS]
ADRENAL CORTEX (Zona Reticularis)
├─ Regulatory Hormone: Adrenocorticotropic Hormone (ACTH)
├─ Key Enzymes: 17α-Hydroxylase & Sulfotransferase (SULT2A1)
└─ Primary Output: DHEA-S (> 99% of body total) & DHEA (~50%)
OVARIES (Theca Cells)
├─ Regulatory Hormone: Luteinizing Hormone (LH)
├─ Key Enzymes: 17β-HSD & Aromatase (CYP19A1)
└─ Primary Output: Testosterone (~25%) & Androstenedione (~50%)
PERIPHERAL TISSUES (Liver, Adipose, Skin)
└─ Primary Pathway: Converts circulating Androstenedione into Testosterone (~50%)
In adult women:
- Over 99% of circulating dhea-sulfate is produced exclusively by the zona reticularis of the adrenal cortex. The adrenal enzyme SULT2A1 attaches a sulfate group to free DHEA, creating a stable, long-lasting reservoir with a half-life of 7 to 10 hours (compared to free DHEA's half-life of just 15 to 30 minutes).
- By contrast, circulating total-testosterone originates roughly 25% from the ovaries, 25% from the adrenals, and 50% from peripheral conversion of androstenedione in adipose tissue and the liver.
Therefore, when testosterone is normal but DHEA-S is elevated, the ovaries are almost entirely innocent. The signal is originating squarely within the adrenal cortex.
2. The Primary Causes of Isolated High DHEA-S#
When an isolated DHEA-S elevation is detected in a woman, endocrinologists work through four primary diagnostic possibilities:
A. Adrenal PCOS (HPA Axis Hypersensitivity)#
Approximately 10% to 20% of women diagnosed with PCOS have what functional endocrinologists categorize as Adrenal PCOS.
Unlike classic "metabolic" PCOS: which is driven by high insulin stimulating ovarian theca cells to overproduce testosterone: women with Adrenal PCOS have normal fasting insulin, normal HbA1c, and normal testosterone.
Instead, their adrenal glands exhibit an exaggerated androgenic response to normal pulses of Adrenocorticotropic Hormone (ACTH). Even under modest physical or emotional stress, their zona reticularis preferentially channels steroid precursors into DHEA-S rather than cortisol.
B. Non-Classic Congenital Adrenal Hyperplasia (NCAH)#
NCAH is an inherited autosomal recessive condition caused by mild partial mutations in the CYP21A2 gene, resulting in partial deficiency of the 21-hydroxylase enzyme.
[STEROIDOGENIC BLOCK IN 21-HYDROXYLASE DEFICIENCY]
CHOLESTEROL
│
▼
17-HYDROXYPROGESTERONE (17-OHP)
│
├─► [BLOCKED: Partial 21-Hydroxylase Deficiency] ──X──► Cortisol
│
▼ (Precursors are shunted sideways into the androgen pathway)
DHEA ──► DHEA-SULFATE (SULT2A1) ──► ELEVATED ANDROGENS
Because the enzymatic pathway to cortisol is partially blocked, steroid precursors accumulate behind the bottleneck. The body shunts these excess precursors sideways into the adrenal androgen pathway, driving DHEA-S upward.
NCAH affects roughly 1 in 1,000 women (and up to 1 in 30 in specific populations, such as Ashkenazi Jewish individuals). It is clinically indistinguishable from PCOS without specific laboratory testing.
C. Chronic Sympathetic Nervous System and HPA Stress#
The adrenal cortex does not operate in isolation. Chronic psychological stress, intense overtraining, chronic sleep deprivation, or unmanaged emotional trauma leads to sustained hypothalamic release of Corticotropin-Releasing Hormone (CRH).
While the zona fasciculata produces cortisol to manage stress, the adjacent zona reticularis responds to the same ACTH stimulation by upregulating DHEA and DHEA-S production.
D. Exogenous DHEA Supplementation#
DHEA is widely available over-the-counter in the United States and is commonly recommended in fertility protocols (to improve ovarian reserve) and anti-aging regimens.
Oral DHEA undergoes massive first-pass hepatic metabolism, where liver sulfotransferases rapidly convert free DHEA into DHEA-S. A modest daily dose of 25 mg of DHEA can easily push serum DHEA-S above 500 to 700 ug/dL.
E. Adrenal Cortical Neoplasms (Rare)#
Although rare, benign adrenal adenomas or adrenocortical carcinomas can autonomously hyper-secrete DHEA-S independently of ACTH. Autonomous tumors are strongly suspected when DHEA-S exceeds 700 to 800 ug/dL (or > 18 to 20 umol/L) or when androgen levels rise abruptly alongside rapid virilization (deepening voice, clitoromegaly, severe male-pattern alopecia).
3. Diagnostic Algorithm: The Step-by-Step Workup#
If your blood work reveals an isolated high DHEA-S, follow this systematic diagnostic evaluation:
[DIAGNOSTIC ALGORITHM FOR HIGH DHEA-S IN WOMEN]
ISOLATED HIGH DHEA-S (Normal Total & Free Testosterone)
│
├─► Check Magnitude of Elevation:
│ ├─► Extreme (> 700 - 800 ug/dL): Order Adrenal CT/MRI to rule out neoplasm
│ └─► Mild-to-Moderate (350 - 650 ug/dL): Proceed with functional workup
│
├─► Rule Out Non-Classic CAH (NCAH)
│ └─► Draw Morning 17-Hydroxyprogesterone (17-OHP) at 8:00 AM in Follicular Phase
│ ├─► < 200 ng/dL (6 nmol/L): NCAH Ruled Out
│ ├─► 200 - 1,000 ng/dL: Equivocal; perform Cosyntropin (ACTH) Stimulation Test
│ └─► > 1,000 ng/dL: Diagnostic of 21-hydroxylase deficiency
│
├─► Screen for Secondary Pituitary Drivers
│ ├─► Serum Prolactin (Hyperprolactinemia stimulates adrenal androgens)
│ └─► TSH (Hypothyroidism impairs adrenal clearance)
│
└─► Assess Adrenal PCOS & Stress Axis
├─► Fasting Insulin & HOMA-IR (Confirm metabolic vs adrenal subtype)
├─► Pelvic Ultrasound (Evaluate ovarian antral follicle count)
└─► 4-Point Salivary Cortisol Rhythm (Evaluate diurnal HPA curve)
The Critical Timing of 17-Hydroxyprogesterone (17-OHP)#
To accurately rule out NCAH, [17-hydroxyprogesterone] must be drawn:
- At 8:00 AM: When ACTH-driven steroidogenesis peaks.
- During the Early Follicular Phase (Days 3 to 5 of the menstrual cycle): Progesterone and 17-OHP naturally rise substantially during the luteal phase after ovulation, which can produce a false positive test for NCAH if drawn late in the cycle.
4. Laboratory Comparison: Adrenal vs Ovarian Androgen Excess#
Comparing your complete hormone panel clarifies whether your symptoms stem from your adrenals, your ovaries, or a mixed presentation:
| Biomarker | Optimal Female Target | Adrenal PCOS / Stress | Classic Ovarian PCOS | Non-Classic CAH |
|---|---|---|---|---|
| DHEA-S | 120 - 280 ug/dL | High (350 - 650) | Normal or Mild High | Markedly High (> 500) |
| Total Testosterone | 15 - 45 ng/dL | Normal (20 - 40) | High (> 50 - 75) | Normal or Mild High |
| Free Testosterone | 0.5 - 3.5 pg/mL | Normal (< 3.0) | High (> 4.5 - 9.0) | Normal or High |
| 17-OHP (8:00 AM) | < 100 ng/dL | Normal (< 150) | Normal (< 200) | Diagnostic (> 200 - 1,000+) |
| Fasting Insulin | 2.0 - 5.0 uIU/mL | Normal (3 - 6) | High (> 10 - 25) | Normal |
| LH / FSH Ratio | ~ 1:1 | Normal (~ 1:1) | Elevated (> 2:1 or 3:1) | Variable |
To understand how bioavailable androgens behave in contrast to total hormone levels, review our clinical guide on Free vs Total Testosterone.
5. Pre-Analytical Precautions for Androgen Testing#
Adrenal hormones are exceptionally reactive to timing and phlebotomy conditions:
- Cycle Timing: If you have regular cycles, draw blood between Day 3 and Day 5 after menstruation begins (the early follicular phase). This standardizes baseline ovarian and adrenal steroid output.
- Morning Blood Draw (7:30 to 9:00 AM): ACTH and adrenal steroidogenesis follow a strict circadian rhythm, declining by 30% to 50% from morning to late afternoon.
- Discontinue DHEA Supplements: Stop any oral DHEA, pregnenolone, or adrenal glandular formulas for at least 14 days before testing.
- Stress Minimization: Arrive at the clinic 15 minutes before your draw and sit quietly. Acute panic or running up stairs spikes ACTH, leading to a transient surge in adrenal androgen output.
6. Actionable Protocol to Support Adrenal Balance#
If your evaluation confirms Adrenal PCOS or stress-mediated DHEA-S elevation:
A. Regulate HPA Axis Tone#
- Sleep Regularity: Prioritize 7.5 to 8.5 hours of sleep with a consistent bedtime. Sleep fragmentation is one of the most potent non-psychological drivers of elevated nocturnal ACTH secretion.
- Adaptogenic Herbal Support: Clinical trials support the use of standardized Ashwagandha (KSM-66, 300 to 600 mg daily) and Phosphatidylserine (300 to 400 mg at night) to blunt excessive hypothalamic CRH and pituitary ACTH surges.
B. Evaluate Micronutrients for Steroid Hydroxylation#
- Vitamin C: The adrenal glands maintain the highest concentration of ascorbic acid in the human body, using it as an essential cofactor during steroidogenesis.
- Magnesium Glycinate (300 to 400 mg): Calms central sympathetic outflow and supports healthy hepatic androgen glucuronidation and clearance.
C. Re-assess Exercise Intensity#
Intense chronic high-intensity interval training (HIIT) or exhaustive endurance cardio without adequate recovery keeps the sympathetic nervous system locked in fight-or-flight mode. Transitioning toward resistance training with longer rest periods, walking, and yoga frequently lowers DHEA-S within 8 to 16 weeks.
7. How Meridian Empowers Sovereign Endocrine Surveillance#
Hormonal health is dynamic and complex. A single high DHEA-S test does not define your biology; its clinical meaning depends on its trajectory alongside your metabolic markers, sleep metrics, and ovarian hormones over time.
Meridian provides a sovereign home for your endocrine data:
- Instant On-Device Extraction: Scan lab PDFs from Quest, Labcorp, or private clinics using your iPhone camera. Apple VisionKit captures DHEA-S, Total Testosterone, Free Testosterone, serum-prolactin, and thyroid-stimulating-hormone in under one second.
- Longitudinal Multi-Pillar Corroboration: Plot your adrenal androgens against your fasting insulin, cortisol rhythm, and metabolic indices on an unified timeline.
- 100% Offline Vault Architecture: Your private endocrine and reproductive health records are encrypted on your device using AES-256 within the Apple Secure Enclave. Zero cloud storage, zero tracking, zero third-party monetization.
Frequently Asked Questions#
Does high DHEA-S always cause physical symptoms?#
No. Many women with mild-to-moderate elevations in DHEA-S (350 to 450 ug/dL) experience zero symptoms. However, because DHEA-S can convert downstream in peripheral tissues into more potent androgens, some women experience cystic jawline acne, facial hirsutism, oily skin, or crown hair thinning.
Can high DHEA-S cause weight gain?#
DHEA-S itself is an androgenic neurosteroid that promotes lean mass rather than fat accumulation. However, because high DHEA-S is frequently triggered by chronic HPA axis stress, the concurrent elevation in nocturnal cortisol can promote central visceral fat storage, fluid retention, and carbohydrate cravings.
Is DHEA-S high in all types of PCOS?#
No. Classic metabolic PCOS is characterized primarily by high ovarian testosterone and elevated fasting insulin. High DHEA-S is present in only about 20% to 30% of PCOS cases, and represents an isolated finding in "Adrenal PCOS" where ovarian testosterone and insulin are completely normal.
When should a high DHEA-S be investigated for an adrenal tumor?#
Endocrinologists typically consider adrenal imaging (high-resolution adrenal CT or MRI) if DHEA-S exceeds 700 to 800 ug/dL (or > 18 to 20 umol/L), or if high androgen levels are accompanied by rapid, progressive virilization (such as deepening voice, significant hair loss, or clitoromegaly) over a short multi-month window.